Back to top
more

Medpace (MEDP)

(Real Time Quote from BATS)

$429.85 USD

429.85
67,921

+8.54 (2.03%)

Updated Jul 22, 2024 11:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Here's Why You Should Retain Walgreens Boots (WBA) For Now

Investors are optimistic about Walgreens Boots (WBA), led by strategic alliances and new product launches.

Boston Scientific (BSX) Rides on Emerging Markets, MedSurg

Boston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and pulmonary treatment options.

Veracyte's (VCYT) New Findings to Advance Thyroid Cancer Care

Veracyte's (VCYT) new studies leverage Afirma GRID's whole-transcriptome approach to uncover novel molecular signatures and alterations.

Globus Medical (GMED) Hits 52-Week High: What's Driving It?

Globus Medical (GMED) outperforms the industry due to its stellar quarterly performance and impactful launches.

Intuitive Surgical (ISRG) Hits 52-Week High on Procedure Demand

Intuitive Surgical's (ISRG) da Vinci procedure volume, coupled with strong Ion procedure growth, is fueling the rally in the company???s share price.

CVS Health (CVS) Expands Food and Beverage Line With New Launch

CVS Health's (CVS) Well Market brand offers a blend of mouthwatering flavors and nutritious options, expertly crafted and taste-tested by food enthusiasts.

Bruker (BRKR) Gains Market Share on Innovation Amid Macro Woes

Bruker's (BRKR) BSI Nano business is seeing robust revenue growth across its end markets, including academic, government, industrial and semiconductor metrology.

Here's Why You Should Buy Haemonetics (HAE) Stock Now

Strong prospects of the Plasma franchise and favorable solvency bode well for Haemonetics (HAE).

Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade

Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.

Evolus (EOLS) Releases Favorable Dermal Fillers Study Data

The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?

Investors are optimistic about Veracyte (VCYT) led by strength in the testing business and upbeat guidance.

Here's Why You Should Hold on to Abbott (ABT) Stock for Now

Abbott's (ABT) share recovery in the Nutrition business buoys optimism.

IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues

IDEXX (IDXX) is being hurt by geopolitical instability, including the current war in Ukraine, which has affected supply chain operations globally.

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.

Here's Why Investors Should Buy ResMed (RMD) Stock Now

Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.

Boston Scientific (BSX) mCRM System Study Outcome Favorable

Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.

Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome

Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.

Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid

Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.

Maravai (MRVI) Advances in RNA Research With New Collaboration

Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.

Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?

Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.

Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?

Tandem Diabetes (TNDM) outperforms the industry, owing to its impressive series of product launches and an impressive quarterly performance.

Tirthankar Chakraborty headshot

4 Best Momentum Stocks Worth a Buy Using Driehaus Strategy

Stocks like Wingstop (WING), Medpace (MEDP), Comfort Systems USA (FIX) and HCI Group (HCI) have been selected as the momentum picks for the day using the Driehaus strategy.

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.